Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager

All categories
DBCAT005778Pharmacologic class

A DrugBank category of 2 drugs. 2 of them are approved.

Part of
Bispecific Monoclonal Antibodies
Drugs

What you can answer from here — as of October 26, 2022

2DrugsEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
19Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In